米兰体育-米兰体育官网
米兰(中国)体育官方网站-AC Milan1对一在线教授19年最新玩法
学员帐号全年数据跟踪并指导

美律所对江波制药提起集体诉讼‘米兰体育’

NEWYORK,Aug.3,2011(GLOBENEWSWIRE)--MilbergLLPtodayannouncedthatonAugust2,2011,thefirmfiledaclassactionlawsuitonbehalfofinvestorswhopurchasedthesecuritiesofJiangboPharmaceuticals,Inc.("Jiangbo"orthe"Company")(Nasdaq:JGBO)duringtheperiodJune

二维码
本文摘要:NEWYORK,Aug.3,2011(GLOBENEWSWIRE)--MilbergLLPtodayannouncedthatonAugust2,2011,thefirmfiledaclassactionlawsuitonbehalfofinvestorswhopurchasedthesecuritiesofJiangboPharmaceuticals,Inc.("Jiangbo"orthe"Company")(Nasdaq:JGBO)duringtheperiodJune

米兰体育

NEWYORK,Aug.3,2011(GLOBENEWSWIRE)--MilbergLLPtodayannouncedthatonAugust2,2011,thefirmfiledaclassactionlawsuitonbehalfofinvestorswhopurchasedthesecuritiesofJiangboPharmaceuticals,Inc.("Jiangbo"orthe"Company")(Nasdaq:JGBO)duringtheperiodJune8,2010,toMay31,2011,inclusive(the"ClassPeriod").Thecase,Lewisv.JiangboPharmaceuticals,Inc.,No.1:11-cv-22788-PAS,ispendingintheUnitedStatesDistrictCourtfortheSouthernDistrictofFloridaandallegesviolationsoftheSecuritiesExchangeActof1934byJiangboandcertainoftheCompany'sofficers.JiangboresearchesanddevelopspharmaceuticalproductsinChina.JiangboproducesbothwesternandChineseherbal-basedmedicaldrugsintablet,capsule,granule,syrup,andelectuaryform.TheComplaintallegesthatthroughouttheClassPeriod,Defendantsmademateriallyfalseandmisleadingstatementstoinvestorsbyma

米兰体育

teriallyoverstatingtheCompany'scashbalancesandfailingtodisclosethatJiangbo'sinternalcontrolsoverfinancialreportingwereinadequate.InMarch2011,theCompany'sChiefFinancialOfficerresigned.OnApril4,2011,theCompanyreportedthatithadreplaceditsauditor.OnMay27,2011,theCompanydisclosedthattheSecuritiesandExchangeCommissionhad,inDecember2010,commencedaninformalinvestigation.OnMay31,2011,NASDAQhaltedtradingofJiangbostock.TheCompanyreceivedadelistingletterfromNASDAQonJuly26,2011.IfyoupurchasedsecuritiesofJiangbofromJune8,2010,toMay31,2011,youmaymovethecourtnolaterthanSeptember14,2011,andrequestthattheCourtappointyouasleadplaintiff.Aleadplaintiffisaclassmemberthatactsonbehalfofotherclassmembersindirectingthelitigation.Yourshareinanyrecoverywillnotbeenhancedordiminishedbyservingasaleadplaintiff,howeve

米兰体育

r,leadplaintiffsmakeimportantdecisionsthatcouldaffecttheoverallrecoveryforclassmembers.Youdonotneedtobealeadplaintifftorecoverinaclassaction;youcanrecoverasanabsentclassmember.YoumayretainMilbergLLP,orotherattorneys,forthisaction,butdonotneedtoretaincounseltorecoverasanabsentclassmember.Ifthisactioniscertifiedasaclassaction,classmemberswillbeautomaticallyrepresentedbycourt-appointedcounsel.ThelawsuitsdiscussedherewerenotfiledbyMilberg.MilbergLLPhasbeenrepresentingindividualandinstitutionalinvestorsformorethanfourdecadesandservesasleadcounselinfederalandstatecourtsthroughouttheUnitedStates.PleasevisittheMilbergwebsiteformoreinformationaboutthefirm.Ifyouwishtodiscussthismatterwithus,orhaveanyquestionsregardingthismatter,pleasecontactthefollowingattorneys:AndreiRado,Esq.JessicaSleater,Esq
本文关键词:美,律所,对,江波,制药,提起,集体,诉讼,‘,米兰体育

本文来源:米兰体育-www.25635440.com

  • 探索网红专业培育
  • 研究多样网红孵化
  • 促进网红经济发展
  • 引领网红米兰(中国)体育官方网站-AC Milan产业升级
0768-863123489
联系米兰(中国)体育官方网站-AC Milan
前台座机: 400-888-8888 招生热线: 0768-863123489 公司地址: 湖北省恩施土家族苗族自治州宣恩县方一大楼749号
Copyright © 2004-2025 www.25635440.com. 米兰体育科技 版权所有  ICP备67761005号-5  XML地图  网站模板